BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 5096513)

  • 1. Relationship of nervous tissue transketolase to the neuropathy in chronic uremia.
    Sterzel RB; Semar M; Lonergan ET; Treser G; Lange K
    J Clin Invest; 1971 Nov; 50(11):2295-304. PubMed ID: 5096513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transketolase inhibition as a mechanism in uremic neuropathy.
    Lange K; Lonergan ET; Semar M; Sterzel RB
    Trans Assoc Am Physicians; 1971; 84():172-81. PubMed ID: 5164301
    [No Abstract]   [Full Text] [Related]  

  • 3. The uremic toxin oxythiamine causes functional thiamine deficiency in end-stage renal disease by inhibiting transketolase activity.
    Zhang F; Masania J; Anwar A; Xue M; Zehnder D; Kanji H; Rabbani N; Thornalley PJ
    Kidney Int; 2016 Aug; 90(2):396-403. PubMed ID: 27198804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte transketolase activity in uremia.
    Kuriyama M; Mizuma A; Yokomine R; Igata A; Otuji Y
    Clin Chim Acta; 1980 Dec; 108(2):169-77. PubMed ID: 6256098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transketolase and myelin.
    Collins RC; Lonergan ET
    N Engl J Med; 1971 Sep; 285(13):751-2. PubMed ID: 4398337
    [No Abstract]   [Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transketolase inhibition and uremic peripheral sensory neuropathy.
    Egan JD; Wells IC
    J Neurol Sci; 1979 May; 41(3):379-95. PubMed ID: 220393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemodialysis on the inhibition of nervous tissue transketolase and on uremic neuropathy.
    Sterzel RB; Semar M; Lonergan ET; Lange K
    Trans Am Soc Artif Intern Organs; 1971; 17():77-9. PubMed ID: 5158138
    [No Abstract]   [Full Text] [Related]  

  • 9. THE REGIONAL DISTRIBUTION OF TRANSKETOLASE IN THE NORMAL AND THE THIAMINE DEFICIENT NERVOUS SYSTEM.
    DREYFUS PM
    J Neuropathol Exp Neurol; 1965 Jan; 24():119-29. PubMed ID: 14253567
    [No Abstract]   [Full Text] [Related]  

  • 10. Uremic neuropathy. Monitoring of transketolase activity inhibition in a child.
    McVicar M; Gauthier B; Goodman CT
    Am J Dis Child; 1973 Feb; 125(2):263-5. PubMed ID: 4265477
    [No Abstract]   [Full Text] [Related]  

  • 11. Encephalopathy of thiamine deficieny: studies of intracerebral mechanisms.
    McCandless DW; Schenker S; Cook M
    J Clin Invest; 1968 Oct; 47(10):2268-80. PubMed ID: 5676522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transketolase activity in uremia.
    Lonergan ET; Semar M; Lange K
    Arch Intern Med; 1970 Nov; 126(5):851-4. PubMed ID: 5475709
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythrocyte transketolase activity in dialyzed patients. A reversible metabolic lesion of uremia.
    Lonergan ET; Semar M; Sterzel RB; Treser G; Needle MA; Voyles L; Lange K
    N Engl J Med; 1971 Jun; 284(25):1399-403. PubMed ID: 4325316
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of ribose-5-phosphate in hemolysates. III. Quantitative determination of sedoheptulose-7-phosphate and some properties of the transketolase of erythrocytes and blood serum.
    BRUNS FH; DUNWALD E; NOLTMANN E
    Biochem Z; 1958; 330(6):497-508. PubMed ID: 13596392
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the thiamine nutritional state of uremic patients by determination of erythrocyte transketolase activity].
    Rizzo SC; Varasi C
    Minerva Nefrol; 1969; 16(4):301-5. PubMed ID: 5397050
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non-uremic neuropathy in hemodialysis patients].
    Kondo H; Takeuchi M; Yatabe K; Mochizuki A; Iwata M
    No To Shinkei; 1997 Aug; 49(8):737-43. PubMed ID: 9282368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte transketolase activity in patients with diabetic and alcoholic neuropathies.
    Michalak S; MichaƂowska-Wender G; Adamcewicz G; Wender MB
    Folia Neuropathol; 2013; 51(3):222-6. PubMed ID: 24114639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate inhibition of transketolase.
    Solovjeva ON; Kovina MV; Kochetov GA
    Biochim Biophys Acta; 2016 Mar; 1864(3):280-282. PubMed ID: 26708478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of transketolase activity in blood].
    Hoffmann I; Knapp A; Rietz K; Milner C
    Clin Chim Acta; 1971 Jul; 33(2):415-21. PubMed ID: 5119318
    [No Abstract]   [Full Text] [Related]  

  • 20. A transketolase assembly defect in a Wernicke-Korsakoff syndrome patient.
    Wang JJ; Martin PR; Singleton CK
    Alcohol Clin Exp Res; 1997 Jun; 21(4):576-80. PubMed ID: 9194907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.